Brief: Advaxis - Entered Into Sales Agreement Pursuant To Which Co May Offer & Sell Up To Aggregate Of $40 Million Of Co's Shares
May 8 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS - ENTERED INTO SALES AGREEMENT PURSUANT TO WHICH
CO MAY
OFFER & SELL, THROUGH OR TO A.G.P., UP TO AGGREGATE OF $40
MILLION OF CO'S SHARES
Source text for Eikon: https://bit.ly/2A4mRpM
Further company coverage: ADXS.O
((Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors